Multi-analyte profiling of ten cytokines in South African HIV-infected patients with Immune Reconstitution Inflammatory Syndrome (IRIS)

AIDS Research and Therapy

Volumn 7, Issue , 2010, Pages

  Worsley, Catherine M ^a   Suchard, Melinda S ^a   Stevens, Wendy S ^a   Van Rie, Annelies ^b   Murdoch, David M ^b,c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b IL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INTERFERON PRODUCTION; PRIORITY JOURNAL; SOUTH AFRICA;

EID: 77957365793     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-7-36     Document Type: Article

References (33)

1. Barker E, Mackewicz CE, Levy JA. Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci USA 1995, 92:11135-11139. 10.1073/pnas.92.24.11135, 40586, 7479952.
2. Elston JWT, Thaker H. Immune reconstitution inflammatory syndrome. Int J STD AIDS 2009, 20:221-224. 10.1258/ijsa.2008.008449, 19304962.
3. Bower M, Nelson M, Thirlwell C, Newsom-Davis T, Mandalia S, Dhillon T, Holmes P, Gazzard BG, Stebbing J. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 2005, 23:5224-5228. 10.1200/JCO.2005.14.597, 16051964.
4. Elliott JH, Vohith K, Saramony S, Savuth C, Dara C, Sarim C, Huffam S, Oelrichs R, Sophea P, Saphonn V, Kaldor J, Cooper DA, Vun MC, French MA. Immunopathogenesis and diagnosis of Tuberculosis and Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome during Early Antiretroviral Therapy. J Infect Dis 2009, 200:1739-1745.
5. French MA. Immune Reconstitution Inflammatory Syndrome: a reappraisal. Clin Infect Dis 2009, 48:101-107. 10.1086/595006, 19025493.
6. Lawn SD, and French MA. Immune reconstitution disease: recent development and implications for antiretroviral treatment in resource-limited settings. Curr Opin HIV AIDS 2007, 2:339-345. 10.1097/COH.0b013e3281a3c0a6, 19372909.
7. van Tieu H, Ananworanich J, Avihingsanon A, Apateerapong W, Sirivichayakul S, Siangphoe U, Klongugkara S, Boonchokchai B, Hammer SM, Manosuthi W. Immunological markers as predictors of Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome in HIV and Tuberculosis coinfected persons in Thailand. AIDS Res. Hum. Retroviruses 2009, 25:1083-1089. 10.1089/aid.2009.0055, 19886838.
8. Bicanic T, Meintjes G, Rebe K, Williams A, Loyse A, Wood R, Hayes M, Jaffar S, Harrison T. Immune reconstitution inflammatory syndrome in HIV-associated Cryptococcal Meningitis: a prospective study. J Acquir Immune Defic Syndr 2009, 51:130-134. 10.1097/QAI.0b013e3181a56f2e, 19365271.
9. Murdoch DM, Venter WDF, Van Rie A, Feldman C. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 2007, 4:9. 10.1186/1742-6405-4-9, 1871602, 17488505.
10. Murdoch DM, Venter WDF, Feldman C, Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 2008, 22:601-610. 10.1097/QAD.0b013e3282f4a607, 18317001.
11. Human Sciences Research Council South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2008: A Turning Tide Among Teenagers?. Human Sciences Research Council., http://www.mrc.ac.za/pressreleases/2009/sanat.pdf
12. Haddow LJ, Easterbrook PJ, Mosam A, Khanyile NG, Parboosing R, Moodley P, Moosa MS. Defining Immune Reconstitution Inflammatory Syndrome: Evaluation of Expert Opinion versus 2 Case Definitions in a South African Cohort. Clin Infect Dis 2009, 49:1424-1432. 10.1086/630208, 19788360.
13. Miller RF, Isaacson PG, Hall-Craggs M, Lucas S, Gray F, Scaravilli F, An SF. Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. Acta Neuropathol 2004, 108:17-23. 10.1007/s00401-004-0852-0, 15085359.
14. Vicenzi E, Biswas P, Mengozzi M, Poli G. Role of pro-inflammatory cytokines and β-chemokines in controlling HIV replication. J Leukoc Biol 1997, 62:34-40.
15. De Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 Human Cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003, 10:133-139. 145264, 12522051.
16. South African Department of Health Full Report of the Joint Health and Treasury Task Team Charged with Examining Treatment Options to Supplement Comprehensive Care for HIV/AIDS in the Public Health Sector. 2003, South African Department of Health., http://www.info.gov.za/issues/hiv/careplan.htm
17. Murdoch DM, Suchard MS, Venter WDF, Mhlangu P, Ottinger JS, Feldman C, van Rie A, Glencross DK, Stevens WS, Weinhold KJ. Polychromatic immunophenotypic characterization of T cell profiles among HIV-infected patients experiencing Immune Reconstitution Inflammatory Syndrome (IRIS). AIDS Res Ther 2009, 6:16. 10.1186/1742-6405-6-16, 2723132, 19607684.
18. Price P, Murdoch DM, Agarwal U, Lewin SR, Elliott JH, French MA. Immune Restoration Diseases Reflect Diverse Immunopathological Mechanisms. Clin Microbiol Rev 2009, 22:651-663. 10.1128/CMR.00015-09, 2772363, 19822893.
19. Roberts L, Passmore JS, Williamson C, Little F, Bebell LM, Mlisana K, Burgers WA, van Loggerenberg F, Walzl G, Siawaya JFD, Karim QA, Karim SSA. Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. AIDS 2010, 24:819-831. 10.1097/QAD.0b013e3283367836, 20224308.
20. Shankar EM, Vignesh R, Murugavel KG, Balakrishnan P, Sekar R, Lloyd CAC, Solomon S, Kumarasamy N. Immune Reconstitution Inflammatory Syndrome in association with HIV/AIDS and tuberculosis: Views over hidden possibilities. AIDS Res Ther 2007, 4:29. 10.1186/1742-6405-4-29, 2216023, 18053126.
21. Stone SF, Price P, Keane NM, Murray RJ, French MA. Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART. HIV Med 2002, 3:21-37. 10.1046/j.1464-2662.2001.00096.x, 12059947.
22. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, Berezovskaya A, Rousset D, Reynes J-M, Goldfeld AE. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000, 105:1317-1325. 10.1172/JCI9918, 315449, 10792007.
23. Seddiki N, Sasson SC, Santner-Nanan B, Munier M, van Bockel D, Ip S, Marriott D, Pett S, Nanan R, Cooper DA, Zaunders JJ, Kelleher AD. Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. Eur J Immunol 2009, 39:391-403. 10.1002/eji.200838630, 19180462.
24. Lim A, Tan D, Price P, Kamarulzaman A, Tan HY, James I, French MA. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS 2007, 21:1525-1534. 10.1097/QAD.0b013e32825eab8b, 17630546.
25. Montes M, Lewis DE, Sanchez C, de Castilla DL, Graviss EA, Seas C, Gotuzzo E, White AC. Foxp3+ regulatory T cells in antiretroviral-naïve HIV patients. AIDS 2006, 20:1669-1671. 10.1097/01.aids.0000238415.98194.38, 16868450.
26. Rallón NI, López M, Soriano V, Garcia-Samaniego J, Romero M, Labarga P, Garcia-Gasco P, González-Lahoz J, Benito JM. Level, phenotype and activation status of CD4+FoxP3+ regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C cirus. Clin Exp Immunol 2009, 155:35-43. 10.1111/j.1365-2249.2008.03797.x, 2665677, 19076827.
27. Suchard MS, Mayne ES, Green VA, Shalekoff S, Donniger SL, Stevens WS, Gray CM, Tiemessen CT. FOXP3 expression is upregulated in CD4+ T cells in progressive HIV-1 infection and is a marker of disease severity. PLoS ONE 2010, 5:e11762. 10.1371/journal.pone.0011762, 2909259, 20668701.
28. Che KF, Sabado RL, Shankar EM, Tjomsland V, Messmer D, Bhardwaj N, Lifson JD, Larsson M. HIV-1 impairs in vitro priming of naïve T cells and gives rise to contact-dependent suppressor T cells. Eur J Immunol 2010, 40:2248-2258. 10.1002/eji.201040377, 20455275.
29. Nigam P, Velu V, Kannanganat S, Chennareddi L, Kwa S, Siddiqui M, Amara RR. Expansion of FOXP3+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian Immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control. J Immunol 2010, 184:1690-1701. 10.4049/jimmunol.0902955, 20053943.
30. Shankar EM, Vignesh R, Velu V, Murugavel KG, Sekar R, Balakrishnan P, Lloyd CAC, Saravanan S, Solomon S, Kumarasamy N. Does CD4+CD25+foxp3+ cell (Treg) and IL-10 profile determine susceptibility to immune reconstitution inflammatory syndrome (IRIS) in HIV disease?. J Inflamm 2008, 5:2.
31. Bourgarit A, Carcelain G, Martinez V, Lascoux C, Delcey V, Gicquel B, Vicaut E, Lagrange PH, Sereni D, Autran B. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 2006, 20:F1-F7. 10.1097/01.aids.0000202648.18526.bf, 16511406.
32. Lang R. Tuning of macrophage responses by Stat3-inducing cytokines: molecular mechanisms and consequences in infection. Immunobiology 2005, 210:63-76. 10.1016/j.imbio.2005.05.001, 16164013.
33. Murray PJ. The JAK-STAT signaling pathway: input and output integration. J Immunol 2007, 178:2623.